Literature DB >> 22889217

The fourth dimension in immunological space: how the struggle for nutrients selects high-affinity lymphocytes.

Felix M Wensveen1, Klaas P J M van Gisbergen, Eric Eldering.   

Abstract

Lymphocyte activation via the antigen receptor is associated with radical shifts in metabolism and changes in requirements for nutrients and cytokines. Concomitantly, drastic changes occur in the expression of pro-and anti-apoptotic proteins that alter the sensitivity of lymphocytes to limiting concentrations of key survival factors. Antigen affinity is a primary determinant for the capacity of activated lymphocytes to access these vital resources. The shift in metabolic needs and the variable access to key survival factors is used by the immune system to eliminate activated low-affinity cells and to generate an optimal high-affinity response. In this review, we focus on the control of apoptosis regulators in activated lymphocytes by nutrients, cytokines, and costimulation. We propose that the struggle among individual clones that leads to the formation of high-affinity effector cell populations is in effect an 'invisible' fourth signal required for effective immune responses.
© 2012 John Wiley & Sons A/S.

Mesh:

Substances:

Year:  2012        PMID: 22889217     DOI: 10.1111/j.1600-065X.2012.01156.x

Source DB:  PubMed          Journal:  Immunol Rev        ISSN: 0105-2896            Impact factor:   12.988


  11 in total

1.  Metabolism and autophagy in the immune system: immunometabolism comes of age.

Authors:  Jeffrey C Rathmell
Journal:  Immunol Rev       Date:  2012-09       Impact factor: 12.988

Review 2.  Update on the challenges and recent advances in cancer immunotherapy.

Authors:  Gianfranco Baronzio; Gurdev Parmar; Irina Zh Shubina; Valter Cassutti; Sergio Giuli; Marco Ballerini; Mikhail Kiselevsky
Journal:  Immunotargets Ther       Date:  2013-06-15

Review 3.  NKG2D: A Master Regulator of Immune Cell Responsiveness.

Authors:  Felix M Wensveen; Vedrana Jelenčić; Bojan Polić
Journal:  Front Immunol       Date:  2018-03-08       Impact factor: 7.561

4.  Antigen-affinity controls pre-germinal center B cell selection by promoting Mcl-1 induction through BAFF receptor signaling.

Authors:  Felix M Wensveen; Erik Slinger; Martijn Ha van Attekum; Robert Brink; Eric Eldering
Journal:  Sci Rep       Date:  2016-10-20       Impact factor: 4.379

Review 5.  Cheating the Hunger Games; Mechanisms Controlling Clonal Diversity of CD8 Effector and Memory Populations.

Authors:  Inga Kavazović; Bojan Polić; Felix M Wensveen
Journal:  Front Immunol       Date:  2018-11-29       Impact factor: 7.561

Review 6.  New Immunometabolic Strategy Based on Cell Type-Specific Metabolic Reprogramming in the Tumor Immune Microenvironment.

Authors:  Ji-Yong Sung; Jae-Ho Cheong
Journal:  Cells       Date:  2022-02-22       Impact factor: 6.600

7.  Stimulation strength controls the rate of initiation but not the molecular organisation of TCR-induced signalling.

Authors:  John C Marioni; Gillian M Griffiths; Arianne C Richard; Claire Y Ma
Journal:  Elife       Date:  2020-05-15       Impact factor: 8.140

8.  BH3-only protein Noxa contributes to apoptotic control of stress-erythropoiesis.

Authors:  Felix M Wensveen; Christian R Geest; Sten F W M Libregts; Ingrid A M Derks; Paul G Ekert; Verena Labi; Andreas Villunger; Martijn A Nolte; Eric Eldering
Journal:  Apoptosis       Date:  2013-11       Impact factor: 4.677

9.  Eomes broadens the scope of CD8 T-cell memory by inhibiting apoptosis in cells of low affinity.

Authors:  Inga Kavazović; Hongya Han; Giulia Balzaretti; Erik Slinger; Niels A W Lemmermann; Anja Ten Brinke; Doron Merkler; Jan Koster; Yenan T Bryceson; Niek de Vries; Stipan Jonjić; Paul L Klarenbeek; Bojan Polić; Eric Eldering; Felix M Wensveen
Journal:  PLoS Biol       Date:  2020-03-17       Impact factor: 8.029

Review 10.  How Changes in the Nutritional Landscape Shape Gut Immunometabolism.

Authors:  Jian Tan; Duan Ni; Rosilene V Ribeiro; Gabriela V Pinget; Laurence Macia
Journal:  Nutrients       Date:  2021-03-02       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.